| For: | Koonsiripaiboon P, Ruamtawee W, Simasingha N, Tanasoontrarat W, Claimon T, Sethasine S. Efficacy of N-acetylcysteine vs dexamethasone in preventing postembolization syndrome post-transarterial chemoembolization in hepatocellular carcinoma: A randomized controlled trial. World J Gastroenterol 2025; 31(31): 109630 [PMID: 40901687 DOI: 10.3748/wjg.v31.i31.109630] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i31/109630.htm |
| Number | Citing Articles |
| 1 |
Padungkeat Karasin, Kittithat Tantitanawat, Chanchai Charonpongsuntorn, Anuchit Suksamai, Sakkarin Chirapongsathorn. The Efficacy of Dexamethasone Versus N‐Acetylcysteine in Prevention of Post‐Embolization Syndrome in Hepatocellular Carcinoma Patients: A Multicenter Randomized, Double‐Blind, Double‐Dummy, Non‐Inferiority Trial. Asia-Pacific Journal of Clinical Oncology 2026; doi: 10.1111/ajco.70127
|
| 2 |
Supatsri Sethasine, Padoemwut Teerawongsakul, Witchakorn Ruamtawee, Nutachat Treerasoradaj, Huttakan Navadurong. Added value of the albumin-bilirubin score in predicting liver-related complications and mortality in metabolic-associated steatotic liver disease. World Journal of Gastroenterology 2025; 31(37): 110829 doi: 10.3748/wjg.v31.i37.110829
Abstract(122) |
Core Tip(108) |
Full Article(HTML)(477)
|
Full Article (PDF)-1894K(128)
|
Full Article with Cover (PDF)-2527K(52)
|
Full Article (XML)-113K(50)
|
Audio-1080K(23)
|
Peer-Review Report-234K(44)
|
Answering Reviewers-210K(38)
|
Supplementary Material-116K(39)
|
Times Cited (3)
|
Total Visits (882)
|
Open
|